As part of MPE’s Year of Action, we are excited to announce the launch of the Early Diagnosis Survey. At MPE, we know that early diagnosis significantly improves the outcomes and quality of life of patients and their experience of healthcare.
This survey seeks to understand the perspectives of myeloma and AL amyloidosis patients, as well as haematologists, on the diagnosis challenges. The survey will take approximately 5 minutes to complete and is available in 26 European languages.
[Please select your language at the top right-hand corner at the start of the survey.]